This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Protein A Resins Market

Market Insights on Protein A Resins covering sales outlook, demand forecast & up-to-date key trends

Protein A Resins Market by Product (Natural Protein A Resin, Recombinant Protein A Resin), Matrix (Agarose Based Matrix, Glass or Silica Based Matrix, Organic Polymer Based Matrix), Application (Immunoprecipitation, Antibody Purification), End User & Region - Forecast to 2021-2031

Protein A Resins Market Snapshot

[275 Pages Report]  The global protein A resins market is valued at US$ 536.6 Mn in 2020 and is expected to surpass US$ 1.2 Bn by 2031, registering a CAGR of 8.1% over the forecast period (2021-2031) according to Future Market Insights (FMI) study.

In terms of product, the market has been bifurcated between natural protein A resin and recombinant protein A resin. Of these, FMI has forecast the demand for natural protein A resin to account for maximum sales in the protein A resin market through the assessment period.

Data Points

Market Insights

Market Value 2020

US$ 536.6 Mn

Market Value 2021

US$ 569.0 Mn

CAGR 2021-2031

8.1%

Key Players

The key players in Protein A Resins market are Repligen, Danaher (Cytiva Lifesciences), Merck Millipore, Bio-Rad Laboratories, Inc. Thermo Fisher Scientific Inc., and Perkinelmer, Inc

Customize this Report

Let us know your requirement to get
100% FREE customization

2016-2020 Protein A Resins Demand Outlook Compared to 2021-2031 Forecast

According to Future Market Insights (FMI), the sales of protein A resins have grown at a CAGR of nearly 4.8% between 2016 and 2020. Increasing research on monoclonal antibodies (mAbs), CMOs role in mAbs manufacturing, wide therapeutic application of mAbs, production of next-generation protein A resins overcoming ligand leaching issues, and favorable government policies and funding are expected to drive the sales of protein A resins and also provides a positive impetus on the market growth.

Manufacturers are investing in research and development activities to develop advanced protein A chromatography resins or its alternatives to address the high cost and operational bottlenecks associated with it. Followed by merger, acquisition, collaboration and product launches through extensive R&D for strengthening product portfolio is the key strategies adopted by manufacturers to increase their revenue. By adopting these strategies, it helped the companies to expand their regional presence as well as product offerings.

Protein A Resins Market Download Report Brochure

For Instance, In September 2021, Purolite Life Sciences announced the commercialization of two novel next-generation chromatography resins, Praesto® Jetted A50 HipH, and Praesto® Jetted (dT)18-DVB , in association with Repligen.

In June 2021, Thermo Fisher Scientific Inc. collaborated with Newomics, a commercial-stage biotechnology company, to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform which can support various LC−MS applications. The agreement will help improve the throughput and robustness of microflow LC-MS in proteomics and biopharmaceutical applications.

Future Market Insights expects the global protein A resins to grow at a CAGR of 8.1% by the end of 2031. The growth is attributed to rising number of research and development activities for innovative technology development and major companies which are actively participating in approval, partnership, collaboration, merger and acquisitions to expand their market presence and strengthen product portfolios.

How are Contract Manufacturing Organizations (CMOs) Contributing Towards Growth of the Market?

Increasing production of monoclonal antibodies in contract manufacturing organizations is expected to drive revenue growth for the overall protein A resins market over the forecast period. The trend for manufacturing biologics in CMOs started in the 1980s. Over the last few years, the trend in CMOs has changed drastically, shifting from the manufacturing of blockbuster drugs to specialist care drugs, including monoclonal antibodies.

Very few companies have in-house manufacturing capabilities. The management of the supply chain adds to the complexity of manufacturing processes. The establishment of such high-containment biologic facilities requires higher investment, which can be a great financial risk. Thus, contract manufacturing organizations (CMOs) are outsourced the development and production of monoclonal antibodies, driven by increasing need of biotechnology companies that require unique, development expertise, and facilities.

Contract manufacturing organizations are expected to play an important role in the production of active pharmaceutical ingredients and biologics, including monoclonal antibodies, thereby, opening up the new revenue pockets in the protein A resins.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Key Opportunities for Market Players?

The increasing prevalence of cancer is expected to increase the production of monoclonal antibodies for use in therapeutic areas. The potential application of monoclonal antibodies in the diagnosis and treatment of various cancers types has been widely accepted. Each cancer type requires a unique treatment. Thus, it will ultimately provide opportunities for market players by driving sales of protein A resin over the forecast period.

Increasing use of monoclonal antibodies in various therapeutic areas owing to their flexibility and specificity and the need for protein A resin for the same, is expected to drive the sales of protein A resins over the forecast period.

Many pharmaceutical and biotechnological companies are performing research and development (R&D) on monoclonal antibodies to find new therapeutic areas. Companies are already manufacturing monoclonal antibodies products for therapeutic areas such as cardiovascular, immune therapy, microbial infections, inflammatory disorders, Crohn’s disease, transplants, and certain types of cancer such as leukaemia, breast cancer, among others.

The biologics segment in the life sciences industry has gained major acceptance by biotechnology and other research institutes for their areas of research, as it has shown promising results as well as low side effects in the treatment of different diseases, such as cancer, autoimmune diseases, and certain genetic conditions.

Biologic therapies, being more target-mediated than non-biologic treatments, are also used as a first-line treatment in some cancer cases. Biologics is the fastest-growing segment in the healthcare industry, with monoclonal antibodies being the key product.

The growing biologics segment is thus expected to offer lucrative growth opportunities for protein A resin manufacturers in the near future.

What is the Impact of the COVID-19 Crisis on the Market?

Due to COVID 19 outbreak, there has been a gradual rise in growth exhibited by the protein A resins market. Consequently, bioprocessing and related supplies and support activities is expected to increase. This will significantly increase the pandemic- and infectious disease-related R&D and manufacturing for respective drugs and therapies by companies and governments.

Lockdown imposed due to COVID-19 caused supply chain disruptions and discontinued business operations, which compelled several biopharma companies to wait for the availability of the new batches of raw material for protein A resins production.

Disruptions in supply chain hampered the biopharmaceutical production activities due to the shortage of man power, which is also expected to restrain the growth to an extent. But this is a short term impact and a steady growth is expected in the coming years as the pandemic will result in more product, supply, and service companies exercising more control over their supply chains, including reaching further upstream to more suppliers.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Remain a Key Market for Protein A Resins?

In 2021, the U.S. is estimated to account for over 93.5% value share in North America. The demand for protein A resin is increasing in the U.S due to increasing number of biopharmaceutical companies focusing on the development and commercial manufacturing of biosimilar drugs in the region. Besides this, improvement in the quality control systems will continue augmenting growth in North America.

Why is the UK Considered a More Lucrative Market within Europe?

The U.K. is expected to account for nearly 24.1% of the market in Europe by 2031. The rise in demand for protein A resins in UK is primarily due to increasing requirement for protein therapeutics for the treatment of chronic diseases, presence of well-established biotechnology and pharmaceutical companies and rising government funding. Furthermore, favorable regulatory scenario are likely to offer up new opportunities for the protein A resins market in UK.

What are the Factors Supporting Protein A Resins Sales in China?

The China market is expected to register 9.8% CAGR in the East Asia market through the forecast period. The increasing use of biomaterials in drug research, adoption of advanced technologies to leverage healthcare research, expansion of the pharmaceutical industry, and the rising need for vaccines and other therapeutics are the major factors driving the growth in China.

Besides this, favorable government policies and growing funding towards expansion of healthcare infrastructure will create a conducive environment for growth in China.

Category-wise Insights

Why is the demand for natural protein A resins rising?

In terms of product, the natural protein A resins will hold the maximum share of 62.8% in 2021,. Natural protein A is derived from a bacterial cell of the staphylococcus aureus species and mainly used in the purification of monoclonal antibodies. It helps in minimizing ligand leaching and stability issues of traditional protein A resins.

What is driving sales in agarose based matrix segment?

In terms of matrix, the agarose based matrix of protein A resins will account for 85.8% of the market share in 2021 indicating the highest demand in the market. Agarose based matrix offers high binding specificity when compared with other matrices and are therefore widely used for the attachment of ligands that bind proteins. This trend is expected to continue, driving growth in the segment through the forecast period.

Which is the chief application of protein A resins?

By application, the antibody purification of protein A resins segments will account for 74.8% of the market share in 2021. Sales in the segment are primarily steered by demand from large-scale industries like biopharmaceuticals for the isolation of monoclonal antibodies.

Who is the leading end user?

By end user, the biopharmaceutical manufacturers will account for 79.2% of the market share in 2021. The rising demand for protein engineering with various advancements and harnessing new scientific advances is likely to fuel demand in the segment.

Competitive Landscape

Companies operating in the protein A resins market are actively seeking to strengthen their position through approval, collaborations, merge & acquisition partnerships, agreements with established as well as emerging market players. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

In June 2021, Bio-Rad Laboratories, Inc. partnered with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.

In September 2021, Thermo Fisher Scientific Inc. announced the establishment of a new manufacturing plant in Nashville for the production of single-use technology products, which will enable a reliable supply of critical materials used in the production of new biologics and vaccines.

In June 2020, Kaneka Corporation and the National Institute of Infectious Diseases collaborated on a joint project on the development of virus-neutralizing antibodies for the treatment of novel coronavirus infection. The collaboration was made to accelerate the development of therapeutic drugs for treating COVID-19. The financial support for the same was provided by the Japan Agency for Medical Research and Development (AMED) as a COVID-19 therapeutic drug development program.

In March 2020, Danaher acquired Cytiva, a life sciences division with biopharma business of General Electric Company (GE), for a cash purchase price of approximately US$ 20.7 Bn.

In February 2021, Purolite Life Sciences commercially launched NGL COVID-19 Spike Protein Affinity Resin, a novel affinity resin utilized in the purification of COVID-19 vaccines.

The greater the demand for active product, the stronger is the pipeline, which will lead to increase demand for the market. Leading industry players are focusing on the development and launch of the technological advanced protein A resins. There are huge opportunities for the market players to invest in the protein A resins.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Product, Matrix, Application, End User and Region

Key Companies Profiled

  • GE Healthcare
  • Thermo Fisher Scientific
  • Kaneka Corporation,
  • JNC Corporation
  • Purolite Life Sciences
  • Bio-Rad Laboratories, Inc.
  • JSR Corporation (JSR Life Sciences LLC)
  • Repligen
  • Tosoh Bioscience, Merck Group (Merck Millipore)
  • Novasep Holdings SAS, Agilent Technologies, Inc.
  • GenScript, Abcam PLC (Expedeon Ltd.)
  • Avantor Inc.
  • Takara Bio, PerkinElmer, Inc.
  • Suzhou Nanomicro Technology Co., Ltd

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Protein A Resins by Category

Product:

  • Natural Protein A Resin
  • Recombinant Protein A Resin

Matrix:

  • Agarose Based Matrix
  • Glass or Silica Based Matrix
  • Organic Polymer Based Matrix

Application:

  • Immunoprecipitation
  • Antibody Purification

End User:

  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global protein A resins market is projected to register growth at a CAGR of 8.1% between 2021 and 2031 owing  to the increasing demand for biologics production including monoclonal antibody and biosimilars.

North America currently holds the largest share in the global protein A resins market. North America currently holds 35.7% of the global market share.

The demand for protein A resins in India is likely to grow at high rate during the forecast period, accounting for over half of demand in the South Asian market. The primary factors aiding growth are increased R&D activities, expansion of pharmaceutical sector,  and entry of the international market players.

Increasing research on monoclonal antibodies (mAbs), increasing CMOs role in mAbs manufacturing, wide therapeutic application of mAbs, production of Next-generation protein A resins to overcome ligand leaching issues, advent of cost effective protein A resins, favorable government policies and funding, and growing market consolidation activities by manufacturers will aid the global market expansion.

Korea’s protein A resins market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.2% CAGR during the forecast period. Japan market expected to exhibit healthy growth of 7.8% CAGR during the forecast period.

U.S., China, U. K., Japan and India are the top 5 countries that are driving the demand for protein A resins

Leading companies of protein A resins are GE Healthcare, Thermo Fisher Scientific, Kaneka Corporation, JNC Corporation, Purolite Life Sciences, Bio-Rad Laboratories, Inc., JSR Corporation (JSR Life Sciences LLC), Repligen, Tosoh Bioscience, Merck Group (Merck Millipore), Novasep Holdings SAS, Agilent Technologies, Inc., GenScript, Abcam PLC (Expedeon Ltd.), Avantor Inc., Takara Bio, PerkinElmer, Inc., Suzhou Nanomicro Technology Co., Ltd.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Spending Outlook

        4.1.3. Per Capita Healthcare Expenditure Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Rising healthcare spending

        4.2.2. Increasing product launches and approvals

        4.2.3. Growing investments in research and development sector

        4.2.4. Localization of globally renowned biopharmaceutical players

        4.2.5. Regulatory Dynamics

        4.2.6. Rising demand for cost effective purification technology 

        4.2.7. Increasing product adoption

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 perspective and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID19 and Impact Analysis

        5.4.1. Revenue By Product 

        5.4.2. Revenue By Matrix

        5.4.3. Revenue By Application

        5.4.4. Revenue Distribution Channel

    5.5. 2020 Market Scenario

    5.6. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Key Success Factors

    6.1. Product Adoption / Usage Analysis

    6.2. Key Strategies Followed By Manufacturers 

    6.3. Recombinant Protein A Resin Stability

    6.4. Regulatory Scenario

    6.5. Value Chain Analysis

7. Global Protein A Resin Market Demand Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (Units) Analysis, 2016-2020 

    7.2. Current and Future Market Volume (Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Protein A Resin Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product 

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Protein A Resin Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031, by Product 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2016–2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2021-2031

        10.3.1. Natural Protein A Resin

        10.3.2. Recombinant Protein A Resin

    10.4. Market Attractiveness Analysis By Product 

11. Global Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031, By Matrix 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Matrix, 2016–2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Matrix, 2021-2031

        11.3.1. Agarose Based Matrix

        11.3.2. Glass or Silica based

        11.3.3. Organic Polymer based

    11.4. Market Attractiveness Analysis By Matrix

12. Global Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031, by Application

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Application, 2016–2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021-2031

        12.3.1. Immunoprecipitation

        12.3.2. Antibody Purification 

    12.4. Market Attractiveness Analysis By Application

13. Global Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By End User, 2016–2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031

        13.3.1. Biopharmaceutical Manufacturers

        13.3.2. Clinical Research Laboratories

        13.3.3. Academic Institutes

    13.4. Market Attractiveness Analysis By End User

14. Global Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2016–2020

    14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2021-2031

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East & Africa 

    14.4. Market Attractiveness Analysis By Region

15. North America Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. By Matrix

        15.3.4. By Application

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Latin America Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Matrix

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Europe Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Rest of Europe

        17.3.2. By Product

        17.3.3. By Matrix

        17.3.4. By Application

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. South Asia Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Product

        18.3.3. By Matrix

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Product

        19.3.3. By Matrix

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Oceania Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020

    20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Matrix

        20.3.4. By Application

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2016–2020

    21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Turkey

            21.3.1.3. Northern Africa

            21.3.1.4. South Africa

            21.3.1.5. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Matrix

        21.3.4. By Application

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Key and Emerging Countries Protein A Resin Market Analysis 2016-2020 and Forecast 2021-2031

    22.1. Introduction

        22.1.1. Market Value Proportion Analysis, By Key Countries

        22.1.2. Global Vs. Country Growth Comparison

    22.2. U.S. Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.2.1. By Product

        22.2.2. By Matrix

        22.2.3. By Application

        22.2.4. By End User

    22.3. Canada Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.3.1. By Product

        22.3.2. By Matrix

        22.3.3. By Application

        22.3.4. By End User

    22.4. Brazil Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.4.1. By Product

        22.4.2. By Matrix

        22.4.3. By Application

        22.4.4. By End User

    22.5. Mexico Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.5.1. By Product

        22.5.2. By Matrix

        22.5.3. By Application

        22.5.4. By End User

    22.6. Argentina Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.6.1. By Product

        22.6.2. By Matrix

        22.6.3. By Application

        22.6.4. By End User

    22.7. Germany Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.7.1. By Product

        22.7.2. By Matrix

        22.7.3. By Application

        22.7.4. By End User

    22.8. Italy Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.8.1. By Product

        22.8.2. By Matrix

        22.8.3. By Application

        22.8.4. By End User

    22.9. France Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.9.1. By Product

        22.9.2. By Matrix

        22.9.3. By Application

        22.9.4. By End User

    22.10. U.K. Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.10.1. By Product

        22.10.2. By Matrix

        22.10.3. By Application

        22.10.4. By End User

    22.11. Spain Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.11.1. By Product

        22.11.2. By Matrix

        22.11.3. By Application

        22.11.4. By End User

    22.12. BENELUX Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.12.1. By Product

        22.12.2. By Matrix

        22.12.3. By Application

        22.12.4. By End User

    22.13. Russia Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.13.1. By Product

        22.13.2. By Matrix

        22.13.3. By Application

        22.13.4. By End User

    22.14. India Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.14.1. By Product

        22.14.2. By Matrix

        22.14.3. By Application

        22.14.4. By End User

    22.15. Thailand Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.15.1. By Product

        22.15.2. By Matrix

        22.15.3. By Application

        22.15.4. By End User

    22.16. Indonesia Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.16.1. By Product

        22.16.2. By Matrix

        22.16.3. By Application

        22.16.4. By End User

    22.17. Malaysia Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.17.1. By Product

        22.17.2. By Matrix

        22.17.3. By Application

        22.17.4. By End User

    22.18. China Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.18.1. By Product

        22.18.2. By Matrix

        22.18.3. By Application

        22.18.4. By End User

    22.19. Japan Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.19.1. By Product

        22.19.2. By Matrix

        22.19.3. By Application

        22.19.4. By End User

    22.20. South Korea Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.20.1. By Product

        22.20.2. By Matrix

        22.20.3. By Application

        22.20.4. By End User

    22.21. Australia Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.21.1. By Product

        22.21.2. By Matrix

        22.21.3. By Application

        22.21.4. By End User

    22.22. New Zealand Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.22.1. By Product

        22.22.2. By Matrix

        22.22.3. By Application

        22.22.4. By End User

    22.23. GCC Countries Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.23.1. By Product

        22.23.2. By Matrix

        22.23.3. By Application

        22.23.4. By End User

    22.24. Turkey Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.24.1. By Product

        22.24.2. By Matrix

        22.24.3. By Application

        22.24.4. By End User

    22.25. Northern Africa Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.25.1. By Product

        22.25.2. By Matrix

        22.25.3. By Application

        22.25.4. By End User

    22.26. South Africa Protein A Resin Market Value (US$) Analysis, 2021 & 2031

        22.26.1. By Product

        22.26.2. By Matrix

        22.26.3. By Application

        22.26.4. By End User

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies 

    23.2. Market Share Analysis of Top Players

    23.3. Market Concentration

    23.4. Market Presence Analysis

        23.4.1. By Regional footprint of Players

        23.4.2. Product foot print by Players

        23.4.3. Channel Foot Print by Players

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Competition Benchmarking

    24.3. Competition Deep Dive 

        24.3.1. GE Healthcare

            24.3.1.1. Overview

            24.3.1.2. Product Portfolio

            24.3.1.3. Sales Footprint

            24.3.1.4. Strategy Overview

                24.3.1.4.1. Marketing Strategy

                24.3.1.4.2. Product Strategy

                24.3.1.4.3. Channel Strategy

        24.3.2. Thermo Fisher Scientific

            24.3.2.1. Overview

            24.3.2.2. Product Portfolio

            24.3.2.3. Sales Footprint

            24.3.2.4. Strategy Overview

                24.3.2.4.1. Marketing Strategy

                24.3.2.4.2. Product Strategy

                24.3.2.4.3. Channel Strategy

        24.3.3. Kaneka Corporation

            24.3.3.1. Overview

            24.3.3.2. Product Portfolio

            24.3.3.3. Sales Footprint

            24.3.3.4. Strategy Overview

                24.3.3.4.1. Marketing Strategy

                24.3.3.4.2. Product Strategy

                24.3.3.4.3. Channel Strategy

        24.3.4. JNC Corporation

            24.3.4.1. Overview

            24.3.4.2. Product Portfolio

            24.3.4.3. Sales Footprint

            24.3.4.4. Strategy Overview

                24.3.4.4.1. Marketing Strategy

                24.3.4.4.2. Product Strategy

                24.3.4.4.3. Channel Strategy

        24.3.5. Purolite Life Sciences

            24.3.5.1. Overview

            24.3.5.2. Product Portfolio

            24.3.5.3. Sales Footprint

            24.3.5.4. Strategy Overview

                24.3.5.4.1. Marketing Strategy

                24.3.5.4.2. Product Strategy

                24.3.5.4.3. Channel Strategy

        24.3.6. Bio-Rad Laboratories, Inc. 

            24.3.6.1. Overview

            24.3.6.2. Product Portfolio

            24.3.6.3. Sales Footprint

            24.3.6.4. Strategy Overview

                24.3.6.4.1. Marketing Strategy

                24.3.6.4.2. Product Strategy

                24.3.6.4.3. Channel Strategy

        24.3.7. JSR Corporation (JSR Life Sciences LLC) 

            24.3.7.1. Overview

            24.3.7.2. Product Portfolio

            24.3.7.3. Sales Footprint

            24.3.7.4. Strategy Overview

                24.3.7.4.1. Marketing Strategy

                24.3.7.4.2. Product Strategy

                24.3.7.4.3. Channel Strategy

        24.3.8. Repligen

            24.3.8.1. Overview

            24.3.8.2. Product Portfolio

            24.3.8.3. Sales Footprint

            24.3.8.4. Strategy Overview

                24.3.8.4.1. Marketing Strategy

                24.3.8.4.2. Product Strategy

                24.3.8.4.3. Channel Strategy

        24.3.9. Tosoh Bioscience

            24.3.9.1. Overview

            24.3.9.2. Product Portfolio

            24.3.9.3. Sales Footprint

            24.3.9.4. Strategy Overview

                24.3.9.4.1. Marketing Strategy

                24.3.9.4.2. Product Strategy

                24.3.9.4.3. Channel Strategy

        24.3.10. Merck Group (Merck Millipore)

            24.3.10.1. Overview

            24.3.10.2. Product Portfolio

            24.3.10.3. Sales Footprint

            24.3.10.4. Strategy Overview

                24.3.10.4.1. Marketing Strategy

                24.3.10.4.2. Product Strategy

                24.3.10.4.3. Channel Strategy

        24.3.11. Novasep Holdings SAS

            24.3.11.1. Overview

            24.3.11.2. Product Portfolio

            24.3.11.3. Sales Footprint

            24.3.11.4. Strategy Overview

                24.3.11.4.1. Marketing Strategy

                24.3.11.4.2. Product Strategy

                24.3.11.4.3. Channel Strategy

        24.3.12. Agilent Technologies, Inc.

            24.3.12.1. Overview

            24.3.12.2. Product Portfolio

            24.3.12.3. Sales Footprint

            24.3.12.4. Strategy Overview

                24.3.12.4.1. Marketing Strategy

                24.3.12.4.2. Product Strategy

                24.3.12.4.3. Channel Strategy

        24.3.13. GenScript

            24.3.13.1. Overview

            24.3.13.2. Product Portfolio

            24.3.13.3. Sales Footprint

            24.3.13.4. Strategy Overview

                24.3.13.4.1. Marketing Strategy

                24.3.13.4.2. Product Strategy

                24.3.13.4.3. Channel Strategy

        24.3.14. Abcam PLC (Expedeon Ltd.)

            24.3.14.1. Overview

            24.3.14.2. Product Portfolio

            24.3.14.3. Sales Footprint

            24.3.14.4. Strategy Overview

                24.3.14.4.1. Marketing Strategy

                24.3.14.4.2. Product Strategy

                24.3.14.4.3. Channel Strategy

        24.3.15. Avantor Inc. 

            24.3.15.1. Overview

            24.3.15.2. Product Portfolio

            24.3.15.3. Sales Footprint

            24.3.15.4. Strategy Overview

                24.3.15.4.1. Marketing Strategy

                24.3.15.4.2. Product Strategy

                24.3.15.4.3. Channel Strategy

        24.3.16. Takara Bio

            24.3.16.1. Overview

            24.3.16.2. Product Portfolio

            24.3.16.3. Sales Footprint

            24.3.16.4. Strategy Overview

                24.3.16.4.1. Marketing Strategy

                24.3.16.4.2. Product Strategy

                24.3.16.4.3. Channel Strategy

        24.3.17. PerkinElmer, Inc.

            24.3.17.1. Overview

            24.3.17.2. Product Portfolio

            24.3.17.3. Sales Footprint

            24.3.17.4. Strategy Overview

                24.3.17.4.1. Marketing Strategy

                24.3.17.4.2. Product Strategy

                24.3.17.4.3. Channel Strategy

        24.3.18. Suzhou Nanomicro Technology Co., Ltd.

            24.3.18.1. Overview

            24.3.18.2. Product Portfolio

            24.3.18.3. Sales Footprint

            24.3.18.4. Strategy Overview

                24.3.18.4.1. Marketing Strategy

                24.3.18.4.2. Product Strategy

                24.3.18.4.3. Channel Strategy

25. Assumptions & Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product 

Table 02: Global Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product 

Table 03: Global Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 04: Global Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 05: Global Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 06: Global Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 07: Global Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 08: North America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 09: North America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 10: North America Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 11: North America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 12: North America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 13: North America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 14: Latin America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 15: Latin America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 16: Latin America Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 17: Latin America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 18: Latin America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 19: Latin America Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 20: Europe Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 21: Europe Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 22: Europe Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 23: Europe Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 24: Europe Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 25: Europe Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 26: South Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 27: South Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 28: South Asia Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 29: South Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 30: South Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 31: South Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 32: East Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 33: East Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 34: East Asia Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 35: East Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 36: East Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 37: East Asia Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 38: Oceania Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 39: Oceania Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 40: Oceania Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 41: Oceania Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 42: Oceania Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 43: Oceania Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 44: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 45: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 46: Middle East & Africa Protein A Resins Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 47: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Matrix

Table 48: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 49: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Protein A Resins Market Revenue Share by Product, 2021E & 2031F

Figure 02: Protein A Resins Market Revenue Share by Matrix, 2021E & 2031F

Figure 03: Protein A Resins Market Revenue Share by Application, 2021E & 2031F

Figure 04: Protein A Resins Market Revenue Share by End User, 2021E & 2031F

Figure 05: Global Protein A Resins Market Volume Analysis, 2016-2020

Figure 06: Global Protein A Resins Market Volume & Y-o-Y Growth (%) Analysis, 2021-2031

Figure 07: Regional Average Pricing Analysis (US$) for Protein A Resins Market (2020)

Figure 08: Global Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 09: Global Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031

Figure 10: Global Protein A Resins Market Absolute $ Opportunity Analysis, 2021-2031

Figure 11: Global Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 12: Global Protein A Resins Market Y-o-Y Growth Projections By Product, 2021-2031

Figure 13: Global Protein A Resins Market Attractiveness, By Product, 2021-2031 

Figure 14: Global Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 15: Global Protein A Resins Market Y-o-Y Growth Projections By Matrix, 2021-2031

Figure 16: Global Protein A Resins Market Attractiveness, By Matrix, 2021-2031 

Figure 17: Global Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 18: Global Protein A Resins Market Y-o-Y Growth Projections By Application, 2021-2031

Figure 19: Global Protein A Resins Market Attractiveness, By Application, 2021-2031 

Figure 20: Global Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 21: Global Protein A Resins Market Y-o-Y Growth Projections By End User, 2021-2031

Figure 22: Global Protein A Resins Market Attractiveness, By End User, 2021-2031 

Figure 23: Global Protein A Resins Market Analysis By Region, 2021 & 2031

Figure 24: Global Protein A Resins Market Y-o-Y Growth Projections By Region, 2021-2031

Figure 25: Global Protein A Resins Market Attractiveness, By Region, 2021-2031 

Figure 26: North America Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 27: North America Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 28: North America Protein A Resins Market Share, By Product (2021)

Figure 29: North America Protein A Resins Market Share, By Matrix (2021)

Figure 30: North America Protein A Resins Market Share, By Application (2021)

Figure 31: North America Protein A Resins Market Share, By End User (2021)

Figure 32: North America Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 33: North America Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 34: North America Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 35: North America Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 36: North America Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 37: Latin America Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 38: Latin America Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 39: Latin America Protein A Resins Market Share, By Product (2021)

Figure 40: Latin America Protein A Resins Market Share, By Matrix (2021)

Figure 41: Latin America Protein A Resins Market Share, By Application (2021)

Figure 42: Latin America Protein A Resins Market Share, By End User (2021)

Figure 43: Latin America Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 44: Latin America Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 45: Latin America Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 46: Latin America Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 47: Latin America Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 48: Europe Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 49: Europe Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 50: Europe Protein A Resins Market Share, By Product (2021)

Figure 51: Europe Protein A Resins Market Share, By Matrix (2021)

Figure 52: Europe Protein A Resins Market Share, By Application (2021)

Figure 53: Europe Protein A Resins Market Share, By End User (2021)

Figure 54: Europe Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 55: Europe Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 56: Europe Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 57: Europe Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 58: Europe Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 59: South Asia Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 60: South Asia Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 61: South Asia Protein A Resins Market Share, By Product (2021)

Figure 62: South Asia Protein A Resins Market Share, By Matrix (2021)

Figure 63: South Asia Protein A Resins Market Share, By Application (2021)

Figure 64: South Asia Protein A Resins Market Share, By End User (2021)

Figure 65: South Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 66: South Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 67: South Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 68: South Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 69: South Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 70: East Asia Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 71: East Asia Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 72: East Asia Protein A Resins Market Share, By Product (2021)

Figure 73: East Asia Protein A Resins Market Share, By Matrix (2021)

Figure 74: East Asia Protein A Resins Market Share, By Application (2021)

Figure 75: East Asia Protein A Resins Market Share, By End User (2021)

Figure 76: East Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 77: East Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 78: East Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 79: East Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 80: East Asia Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 81: Oceania Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 82: Oceania Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 83: Oceania Protein A Resins Market Share, By Product (2021)

Figure 84: Oceania Protein A Resins Market Share, By Matrix (2021)

Figure 85: Oceania Protein A Resins Market Share, By Application (2021)

Figure 86: Oceania Protein A Resins Market Share, By End User (2021)

Figure 87: Oceania Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 88: Oceania Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 89: Oceania Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 90: Oceania Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 91: Oceania Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 92: Middle East & Africa Protein A Resins Market Size (US$ Mn) Analysis, 2016-2020

Figure 93: Middle East & Africa Protein A Resins Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 94: Middle East & Africa Protein A Resins Market Share, By Product (2021)

Figure 95: Middle East & Africa Protein A Resins Market Share, By Matrix (2021)

Figure 96: Middle East & Africa Protein A Resins Market Share, By Application (2021)

Figure 97: Middle East & Africa Protein A Resins Market Share, By End User (2021)

Figure 98: Middle East & Africa Protein A Resins Market Attractiveness Analysis 2021-2031 By Country

Figure 99: Middle East & Africa Protein A Resins Market Attractiveness Analysis 2021-2031 By Product

Figure 100: Middle East & Africa Protein A Resins Market Attractiveness Analysis 2021-2031 By Matrix

Figure 101: Middle East & Africa Protein A Resins Market Attractiveness Analysis 2021-2031 By Application

Figure 102: Middle East & Africa Protein A Resins Market Attractiveness Analysis 2021-2031 By End User

Figure 103: U.S. Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 104: U.S. Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 105: U.S. Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 106: U.S. Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 107: Global Vs. U.S. Growth Comparison

Figure 108: Canada Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 109: Canada Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 110: Canada Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 111: Canada Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 112: Global Vs. Canada Growth Comparison

Figure 113: Brazil Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 114: Brazil Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 115: Brazil Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 116: Brazil Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 117: Global Vs. Brazil Growth Comparison

Figure 118: Mexico Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 119: Mexico Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 120: Mexico Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 121: Mexico Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 122: Global Vs. Mexico Growth Comparison

Figure 123: Argentina Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 124: Argentina Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 125: Argentina Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 126: Argentina Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 127: Global Vs. Argentina Growth Comparison

Figure 128: Germany Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 129: Germany Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 130: Germany Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 131: Germany Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 132: Global Vs. Germany Growth Comparison

Figure 133: Italy Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 134: Italy Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 135: Italy Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 136: Italy Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 137: Global Vs. Italy Growth Comparison

Figure 138: France Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 139: France Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 140: France Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 141: France Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 142: Global Vs. France Growth Comparison

Figure 143: U.K. Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 144: U.K. Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 145: U.K. Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 146: U.K. Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 147: Global Vs. U.K. Growth Comparison

Figure 148: Spain Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 149: Spain Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 150: Spain Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 151: Spain Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 152: Global Vs. Spain Growth Comparison

Figure 153: BENELUX Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 154: BENELUX Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 155: BENELUX Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 156: BENELUX Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 157: Global Vs. BENELUX Growth Comparison

Figure 158: Russia Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 159: Russia Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 160: Russia Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 161: Russia Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 162: Global Vs. Russia Growth Comparison

Figure 163: India Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 164: India Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 165: India Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 166: India Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 167: Global Vs. India Growth Comparison

Figure 167: Thailand Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 169: Thailand Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 170: Thailand Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 171: Thailand Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 172: Global Vs. Thailand Growth Comparison

Figure 173: Indonesia Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 174: Indonesia Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 175: Indonesia Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 176: Indonesia Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 177: Global Vs. Indonesia Growth Comparison

Figure 178: Malaysia Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 179: Malaysia Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 180: Malaysia Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 181: Malaysia Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 182: Global Vs. Malaysia Growth Comparison

Figure 183: China Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 184: China Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 185: China Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 186: China Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 187: Global Vs. China Growth Comparison

Figure 188: Japan Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 189: Japan Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 190: Japan Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 191: Japan Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 192: Global Vs. Japan Growth Comparison

Figure 193: South Korea Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 194: South Korea Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 195: South Korea Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 196: South Korea Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 197: Global Vs. South Korea Growth Comparison

Figure 198: Australia Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 199: Australia Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 200: Australia Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 201: Australia Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 202: Global Vs. Australia Growth Comparison

Figure 203: New Zealand Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 204: New Zealand Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 205: New Zealand Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 206: New Zealand Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 207: Global Vs. New Zealand Growth Comparison

Figure 208: GCC Countries Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 209: GCC Countries Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 210: GCC Countries Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 211: GCC Countries Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 212: Global Vs. GCC Countries Growth Comparison

Figure 213: Turkey Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 214: Turkey Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 215: Turkey Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 216: Turkey Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 217: Global Vs. Turkey Growth Comparison

Figure 218: Northern Africa Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 219: Northern Africa Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 220: Northern Africa Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 221: Northern Africa Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 222: Global Vs. Northern Africa Growth Comparison

Figure 223: South Africa Protein A Resins Market Analysis By Product, 2021 & 2031

Figure 224: South Africa Protein A Resins Market Analysis By Matrix, 2021 & 2031

Figure 225: South Africa Protein A Resins Market Analysis By Application, 2021 & 2031

Figure 226: South Africa Protein A Resins Market Analysis By End User, 2021 & 2031

Figure 227: Global Vs. South Africa Growth Comparison

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Protein Degeneration Therapy Market

Published : October 2021

Healthcare

Protein Labelling Market

Published : January 2017

Healthcare

Protein Crystallization and Crystallography Market

Published : February 2022

Google translate

Protein A Resins Market